Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06395415 · ClinicalTrials.gov registry record · NA
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
A NA study of Cigarette Smoking and Tobacco Products, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT06395415: Recruiting NA study of Cigarette Smoking and Tobacco Products, sponsored by University of Chicago.
NCT06395415 is a NA study of Cigarette Smoking and Tobacco Products that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 46 participants, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06395415, a NA study of Cigarette Smoking and Tobacco Products, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.
Primary Outcome
ENDS cessation will be measured using a modified Timeline Followback Interview using 7-day point prevalence abstinence with study staff and then confirmed via a mailed saliva cotinine test.
Conditions Studied
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL EQUIP
Study Locations (1)
Illinois
- University of Chicago BREATHE Laboratory - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2025-04-25 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06395415 shows while recruiting
NCT06395415 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 175-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 2 interventions - of which Standard Care is the first listed.
NCT06395415 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06395415 about?
NCT06395415 is a clinical study titled "Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults". Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a ...
What is the current status of trial NCT06395415?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2025-04-25. Estimated completion is 2026-08.
What conditions does trial NCT06395415 study?
This clinical trial studies the following conditions: Cigarette Smoking, Tobacco Products, Electronic Nicotine Delivery Systems.
What interventions are being tested in trial NCT06395415?
The interventions under investigation include: Standard Care (BEHAVIORAL), EQUIP (BEHAVIORAL).
Who is sponsoring clinical trial NCT06395415?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06395415 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06395415's enrollment target sits among peer trials
46 36th of 45 higher than 10 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
RECRUITING · NA
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI